AzTrials
AzTrials

Critical IllnessNCT04507451

Respiratory Muscle Training in ICU Patients

A study testing inspiratory and expiratory muscle training and inspiratory and expiratory exercises in people with Critical Illness and Inspiratory Muscle Strength, run by University of Liege at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Respiratory muscle weakness is common after mechanical ventilation and occurs early. This can limit functional recovery. Respiratory muscle training is often neglected in clinical practice. Some data indicates that inspiratory muscle training increases inspiratory muscle strength and quality of life. Read more about this study

Who is it for?
Ages 18 years and older, men only
What is being tested?
inspiratory and expiratory muscle training and inspiratory and expiratory exercises
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteBelgium
Study dates
1 Oct 2020to 1 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patient from mechanical ventilation after at least 24 hours of support
  • collaborative patient

Who cannot join

  • confusion, mental disorder
  • not french speaking
  • pulmonary surgery in the past 12 months
  • external ventricular drain
  • previous pneumothorax or pneumothorax not drained
  • rib fractures
Show all 10Show fewer
  • alveolar hemorrhage
  • hemodynamic instability
  • labial occlusion impossible (face burn, facial paralysis)
  • patient refusal

Trial locations and contacts

1 site in 1 country.

Anne-Françoise Rousseau, MD, PhD contact

+3243667495

afrousseau@chuliege.be

Belgium1 site, 1 recruiting
  • University Hospital of Liège

    Liège, 4000

    Anne-Françoise Rousseau, PhD, +3243667495, afrousseau@chuliege.be

    Recruiting

Other trials in Belgium

About this study

Official title: Inspiratory and Expiratory Muscle Training in Critically Ill Patients Weaned From Mechanical Ventilation

Respiratory muscle weakness is common after mechanical ventilation and occurs early. This can limit functional recovery. Respiratory muscle training is often neglected in clinical practice. Some data indicates that inspiratory muscle training increases inspiratory muscle strength and quality of life. The aim of the study is to assess the impact of combined inspiratory and expiratory muscle training on inspiratory muscle strength. The second aim is to assess the impact of this training program on expiratory muscle strength.

Being tested
inspiratory and expiratory muscle training, inspiratory and expiratory exercises
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • inspiratory and expiratory muscle trainingProcedure or surgery

    inspiratory muscle training using threshold IMT device expiratory muscle training using a bottle filled of water

  • inspiratory and expiratory exercisesProcedure or surgery

    inspiratory exercise using fractionated inspirations expiratory exercise using a bottle filled with water at a minimum level

Study groups in NCT04507451
Study groupRoleWhat they receive
Trained groupExperimentalPatients will benefit from usual respiratory physiotherapy (secretion clearance treatment and recruitment maneuvers), and muscle training. This program will be delivered 5 days a week. Inspiratory muscle training (IMT): using a threshold IMT device with mouthpiece, 5 sets of 6 breaths, intensity is prescribed at 60% of maximal inspiratory pressure for the first set, and then increased to the highest tolerable intensity to allow completion of the 6th breath Expiratory muscle training (EMT): using a bottle filled with water, starting at 5cm and then increased to 8 cm gradually, 5 sets of 6 breaths Training program starts after mechanical ventilation weaning, as soon as the patient is collaborative, and is continued until 1 month after ICU discharge
Receives: Procedure: inspiratory and expiratory muscle training
Untrained groupPlacebo comparatorPatients will benefit from usual respiratory physiotherapy (secretion clearance treatment and recruitment maneuvers), and muscle exercises that are not planned to train muscles. This program will be delivered 5 days a week. Inspiratory exercises: fractionated inspiration, 5 sets of 6 breaths Expiratory exercises: using a bottle filled with water (1 cm) Exercises program starts after mechanical ventilation weaning, as soon as the patient is collaborative, and is continued until 1 month after ICU discharge
Receives: Procedure: inspiratory and expiratory exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in inspiratory muscle strength

    measurement of maximal inspiratory pressure

    Measured: between 7 to 15 days after ICU discharge (compared to ICU discharge)

  2. change in inspiratory muscle strength

    measurement of maximal inspiratory pressure

    Measured: 1 month after ICU discharge (compared to ICU discharge)

Secondary outcomes (6)
  1. change in expiratory muscle strength

    measurement of maximal expiratory pressure

    Measured: between 7 to 15 days after ICU discharge (compared to ICU discharge)

  2. change in expiratory muscle strength

    measurement of maximal expiratory pressure

    Measured: 1 month after ICU discharge (compared to ICU discharge)

  3. respiratory infections

    number of respiratory infections requiring antibiotics after ICU discharge

    Measured: 1 month after ICU discharge

  4. change in dyspnea perception

    assessed using Dyspnea-12 questionnaire (score from 0 to 36, 36 indicating a maximal dyspnea)

    Measured: 1 month after ICU discharge (compared to hospital discharge)

  5. impact of dyspnea on physical activities

    assessed using modified Medical Research Council (m-MRC) score: stage 0 to 4 (last stage indicating a patient too dyspneic to leave house or breathless when dressing)

    Measured: between 7 to 15 days after ICU discharge

  6. impact of dyspnea on physical activities

    assessed using modified Medical Research Council (m-MRC) score: stage 0 to 4 (last stage indicating a patient too dyspneic to leave house or breathless when dressing)

    Measured: 1 month after ICU discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2020
  2. Study start1 Oct 2020
  3. Primary completion1 Sep 2023 (estimated)
  4. Study completion1 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04507451
Sponsor's protocol ID
RESP-USI
Status last verified
Nov 2020
First submitted
1 Aug 2020
Last updated
4 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing inspiratory and expiratory muscle training and inspiratory and expiratory exercises in people with Critical Illness and Inspiratory Muscle Strength, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anne-Françoise Rousseau, MD, PhD (+3243667495, afrousseau@chuliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in inspiratory muscle strength (time frame: between 7 to 15 days after ICU discharge (compared to ICU discharge)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in